RxDoctor Payments Data

Jessica Tomasiewicz, NP

Nurse Practitioner · Elgin, ILNPI 1841516614

Payments from drug & device makers

$3,484in general payments, 2019–2025

Across 172 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$918
  • Amgen$499
  • Novo Nordisk$319
  • AbbVie$273
  • AstraZeneca$259
  • Johnson & Johnson$210
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,484100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,484 in reported general payments places this provider in the 90th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$191,246
Medicare patients
296
Services billed
6,517

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin68$90,524
OzempicSemaglutide43$48,155
EliquisApixaban23$31,398
TrulicityDulaglutide23$27,195
XareltoRivaroxaban24$26,568
MounjaroTirzepatide21$22,492
Spiriva HandihalerTiotropium Bromide13$16,828
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$13,316
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$10,915
Breo ElliptaFluticasone/Vilanterol12$10,465
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$9,304
MyrbetriqMirabegron13$6,880
Atorvastatin Calcium445$4,733
Levothyroxine Sodium387$4,220
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,621

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$918$90,52468 claims
Lilly USA, LLCTrulicity, Mounjaro$142$49,68744 claims
Novo NordiskOzempic$319$48,15543 claims
PfizerEliquis, Premarin, Dilantin$153$34,74946 claims
Johnson & JohnsonXarelto$210$26,56824 claims
GSKTrelegy Ellipta, Breo Ellipta$69$21,38023 claims
Astellas Pharma US IncMyrbetriq$39$6,88013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Elgin

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →